These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Survival of patients with infiltrating tumors of the bladder treated with cystectomy]. Mandron E; Desrez G; Chatelain C Cancer Radiother; 1998 Apr; 2 Suppl 1():39s-42s. PubMed ID: 9749077 [TBL] [Abstract][Full Text] [Related]
24. Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702 [TBL] [Abstract][Full Text] [Related]
25. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Choong NW; Quevedo JF; Kaur JS Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264 [TBL] [Abstract][Full Text] [Related]
26. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder. Otto W; Fritsche HM; Wild PJ; Wieland WF; Hartmann A; Burger M; Hofstädter F; Denzinger S Pathol Res Pract; 2011 Mar; 207(3):161-3. PubMed ID: 21247708 [TBL] [Abstract][Full Text] [Related]
27. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [TBL] [Abstract][Full Text] [Related]
28. [Predictive factors and long term carcinogenic results of patients who no longer have residual tumors (stage pT0) on specimens of total cystectomy carried out for cancer of the bladder]. Hitier M; Marconnet L; Luyckx F; Branchereau J; Braud G; Karam G; Bouchot O; Rigaud J Prog Urol; 2010 Feb; 20(2):130-7. PubMed ID: 20142054 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
30. Plasmacytoid urothelial carcinoma of the bladder. Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884 [TBL] [Abstract][Full Text] [Related]
31. [Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol]. Hoch V; Noll F; Schreiter F Urologe A; 1992 Jul; 31(4):243-6. PubMed ID: 1514212 [TBL] [Abstract][Full Text] [Related]
32. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Volkmer BG; Kuefer R; Bartsch G; Straub M; de Petriconi R; Gschwend JE; Hautmann RE Cancer; 2005 Dec; 104(11):2384-91. PubMed ID: 16245327 [TBL] [Abstract][Full Text] [Related]
33. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485 [TBL] [Abstract][Full Text] [Related]